Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who were previously enrolled in the IPS101A-10 clinical trial and received the treatment called IPS101A.
- People (or their legally authorised representative) who have given written consent to take part in this long-term follow-up study and have agreed to follow all study requirements.
Who may not be able to join:
- People who do not wish to give consent to take part in this follow-up study, or for whom follow-up check-ins are not possible due to death or other reasons.
- People who, in the opinion of the trial investigator, are considered unsuitable because they are unwilling or unable to attend scheduled study visits or meet other study requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82-2-3499-4266
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety Evaluation: Incidence of serious adverse events of special interest; Safety Evaluation: Incidence of serious adverse events (SAEs) and adverse events (AEs); Safety Evaluation: Number of participants with clinically-relevant changes in physical exams; Safety Evaluation: Number of participants with clinically-relevant changes in laboratory test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.